| 0K1R Stock | | | 21.82 0.07 0.32% |
Viridian Therapeutics financial indicator trend analysis is much more than just breaking down Viridian Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Viridian Therapeutics is a good investment. Please check the relationship between Viridian Therapeutics Non Currrent Assets Other and its Total Current Liabilities accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Viridian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more information on how to buy Viridian Stock please use our
How to Invest in Viridian Therapeutics guide.
Non Currrent Assets Other vs Total Current Liabilities
Non Currrent Assets Other vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Viridian Therapeutics Non Currrent Assets Other account and
Total Current Liabilities. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Viridian Therapeutics' Non Currrent Assets Other and Total Current Liabilities is 0.51. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Viridian Therapeutics, assuming nothing else is changed. The correlation between historical values of Viridian Therapeutics' Non Currrent Assets Other and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Viridian Therapeutics are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Non Currrent Assets Other i.e., Viridian Therapeutics' Non Currrent Assets Other and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.51 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Total Current Liabilities
Total Current Liabilities is an item on Viridian Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Viridian Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Viridian Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Viridian Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Viridian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more information on how to buy Viridian Stock please use our
How to Invest in Viridian Therapeutics guide.
Selling General Administrative is likely to gain to about 99.7
M in 2024
Viridian Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Viridian Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Viridian Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Viridian Stock Analysis
When running Viridian Therapeutics' price analysis, check to
measure Viridian Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viridian Therapeutics is operating at the current time. Most of Viridian Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Viridian Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viridian Therapeutics' price. Additionally, you may evaluate how the addition of Viridian Therapeutics to your portfolios can decrease your overall portfolio volatility.